Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 1998, p. 197-198, Vol. 42, No. 1
Department of Internal Medicine, Division of
Infectious Diseases, Department of Veteran's Affairs Medical
Center and Wayne State University School of Medicine, Detroit,
Michigan 48201
Received 7 February 1997/Returned for modification 30 May
1997/Accepted 28 October 1997
The incidence of the various mutations in the genes encoding
topoisomerase IV and DNA gyrase in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus is not known.
Using restriction fragment length polymorphism analysis and DNA
sequencing, we found that in fluoroquinolone- and methicillin-resistant
strains, mutations in grlA and gyrA are quite
likely to be present together. For fluoroquinolone-resistant but
methicillin-susceptible strains, mutations in grlA alone
are more common.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Topoisomerase Mutations in
Fluoroquinolone-Resistant and Methicillin-Susceptible and -Resistant
Clinical Isolates of Staphylococcus aureus
*
Corresponding author. Mailing address: Department of
Internal Medicine, Division of Infectious Diseases, Wayne State
University School of Medicine, C3690 Detroit VA Medical Center, 4646 John R, Detroit, MI 48201. Phone: (313) 576-4487. Fax: (313)
576-1112. E-mail: gkaatz{at}juno.com.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |